Standard Biotools LAB
NASDAQ LAB
$0.73 +0.04 (+5.26%)
As of: Sep 9, 2026 · 2:24 PM EDT

Standard Biotools (LAB) Non Operating Investment Income (2013 - 2015)

Standard Biotools' (LAB) quarterly Non Operating Investment Income came in at $2.3 million in Q4 2015, up 601.81% quarter-over-quarter from $332000.0 in Q3 2014.

Analysis

Standard Biotools (LAB) Non Operating Investment Income (2013 - 2015) Analysis & Trends

Standard Biotools (LAB) has reported Non Operating Investment Income for 3 consecutive years, with $2.3 million the latest figure, recorded in Q4 2015.

  • On a quarterly basis, Non Operating Investment Income changed N/A year-over-year to $2.3 million in Q4 2015; TTM through Dec 2015 was $2.7 million, a 701.81% increase from a year earlier, with the FY2015 full-year figure at $2.3 million, up 601.81% from the prior year.
  • Non Operating Investment Income was $2.3 million for Q4 2015 at Standard Biotools, up from $332000.0 in the prior quarter.
  • Over five years, Non Operating Investment Income peaked at $2.3 million in Q4 2015 and troughed at $332000.0 in Q3 2014.
  • A 3-year average of $1.5 million and a median of $1.8 million in 2013 frame the typical range for Non Operating Investment Income.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Thermo Fisher Scientific 224.92 Bn 220.85 Bn 8.34 Bn -
2 Danaher 144.67 Bn 140.33 Bn 3.61 Bn -
3 Agilent Technologies 41.02 Bn 39.26 Bn 1.04 Bn -
4 Illumina 31.29 Bn 30.12 Bn 770.00 Mn -
5 Revvity 13.86 Bn 12.84 Bn 416.87 Mn -
6 Bio-Techne 11.27 Bn 11.01 Bn 211.39 Mn -
7 Bio-Rad Laboratories 10.12 Bn 8.50 Bn 345.80 Mn 458.00 Mn
8 Repligen 9.31 Bn 8.29 Bn 110.04 Mn -
9 10x Genomics 8.66 Bn 8.10 Bn 112.50 Mn -
10 Standard Biotools 282.14 Mn -194.58 Mn 10.54 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 2.33 Mn
Sep 30, 2014 332,000.00
Mar 31, 2013 1.78 Mn